Internal Medicine, Hematology · Greenville, SC
NPI
1184683435
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
104 Innovation Drive, Suite 2000
Greenville, SC, 29607
Phone (864) 603-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$159K
1,478 services
Medicare patients, 2024
530
Average age 76
Drug cost, 2024
$4.3M
1,195 prescriptions
Company payments, 2025
$1,527
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharif S Khan was code 99215 (office e&m - established), 891 times for 360 patients. In total Sharif S Khan billed 1,478 services in 14 codes, and Medicare paid $159K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 891 | 360 | $120.78 | $108K |
| 99233 Hospital E&M - Subsequent | Facility | 116 | 37 | $89.05 | $10K |
| 99205 Office E&M - New | Office | 115 | 115 | $142.39 | $16K |
| 99214 Office E&M - Established | Office | 113 | 66 | $83.03 | $9,383 |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 44 | $58.70 | $4,461 |
| 99222 Hospital E&M - Initial | Facility | 55 | 54 | $88.09 | $4,845 |
| 99239 Hospital Discharge Management | Facility | 22 | 21 | $85.70 | $1,885 |
| 99223 Hospital E&M - Initial | Facility | 14 | 13 | $130.34 | $1,825 |
By year: 2022 $142K for 1,234 services; 2023 $178K for 1,489 services; 2024 $159K for 1,478 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharif S Khan prescribed most often to Medicare patients was Acyclovir, with 176 prescriptions and refills. In total Sharif S Khan wrote 1,195 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 176 | 243 | 40 | $1,902 |
| Hydroxyurea Generic | 139 | 241 | 26 | $2,512 |
| Eliquis Apixaban | 85 | 101 | 18 | $58K |
| Pomalyst Pomalidomide | 52 | 52 | Under 11 | $1.0M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 50 | 56 | 14 | $126 |
| Lenalidomide Generic | 41 | 41 | Under 11 | $544K |
| Imbruvica Ibrutinib | 34 | 34 | Under 11 | $386K |
| Ninlaro Ixazomib Citrate | 29 | 29 | Under 11 | $387K |
| Revlimid Lenalidomide | 27 | 27 | Under 11 | $455K |
| Pantoprazole Sodium Generic | 26 | 34 | Under 11 | $144 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 25 | 25 | 19 | $269 |
| Ondansetron Hcl Generic | 25 | 25 | Under 11 | $270 |
| Xarelto Rivaroxaban | 22 | 30 | Under 11 | $16K |
| Potassium Chloride Generic | 21 | 31 | Under 11 | $484 |
| Gabapentin Generic | 20 | 33 | Under 11 | $403 |
Brand drugs: 358 claims; generic drugs: 837 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharif S Khan $1,527 ($1,527 in general payments such as food, travel and fees) from 12 companies. The largest payer was Kite Pharma, Inc. with $355.
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. GILD | 3 | $355 |
| Janssen Biotech, Inc. JNJ | 2 | $202 |
| Incyte Corporation INCY | 2 | $193 |
| Adaptive Biotechnologies Corporation ADPT | 2 | $164 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $124 |
| Adc Therapeutics America, Inc. | 1 | $120 |
| Abbvie Inc. ABBV | 1 | $117 |
| GlaxoSmithKline, LLC. GSK | 1 | $113 |
| Amgen Inc. AMGN | 1 | $102 |
| Pfizer Inc. PFE | 1 | $22.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.